Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Iliotibial Band Syndrome

In brief

The goal of this Clinical Trial Study is to evaluate the clinical effectiveness of Radial Electrocorporeal Shockwave Therapy (rESWT) combined with exercise in individuals with iliotibial band syndrome (ITBS).The main question it aims to answer is : Does the addition of rESWT to standard ITBS exercise program reduce pain intensity and pain pressure threshold while improving lower extremity function and hip muscle strength in Individuals with Iliotibial Band syndrome (ITBS). Participants will be divided into two groups to be compared : The ShamTherapy Group (Control Group) that will receive the standard ITBS exercise program in addition to Sham rESWT, while the experimental group will receive the standard ITBS exercise program in addition to Radial Extracorporeal Shockwave Therapy.

Key facts

Study ID

NCT07668011

Run by

Cairo University

People needed

40

Starts

2026-06-10

Expected to finish

2026-08-30

Last updated by the study team

2026-06-25

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Physically active individuals aged 18 and 45 years
• Have a clinical diagnosis of iliotibial band syndrome (ITBS) confirmed by physician within the previous four weeks.
• Report lateral knee pain during running or other functional activities
• No history of direct trauma
• Have a positive Noble compression or/and Ober test.

You may not qualify if…

• History of knee surgery,fracture , meniscal or ligamentous injury within the past year
• Any fracture involving the lower extremity within the previous six months
• Neurological disorders
• Lumbar radiculopathy
• Systemic inflammatory disease
• Any medical condition affecting gat or lower extremity function.
• Have received corticosteroid injection, shockwave therapy, or physical therapy treatment for ITBS within the previous six months
• Use of NDAID's or analgesics later than 2 weeks
• Individuals with contraindications to ESWT, including pregnancy, bleeding disorders, or use of anticoagulant medication.

Where it is running

• Cairo University Hospitals — Giza, Giza Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.